MeSH term
Frequency | Condition_Probility | Aged | 18 | 0.0 |
*Chromosomes, Human, Pair 12 | 25 | 9.0 |
Humans | 102 | 0.0 |
In Situ Hybridization, Fluorescence | 45 | 1.0 |
Male | 54 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 22 | 11.0 |
Reverse Transcriptase Polymerase Chain Reaction | 18 | 0.0 |
Translocation, Genetic/*genetics | 13 | 5.0 |
Animals | 17 | 0.0 |
Bone Marrow Transplantation | 2 | 0.0 |
Chromosomes, Human, Pair 12 | 9 | 5.0 |
Chromosomes, Human, Pair 9 | 2 | 1.0 |
Comparative Study | 5 | 0.0 |
Female | 43 | 0.0 |
Mice | 14 | 0.0 |
Research Support, Non-U.S. Gov't | 87 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Translocation, Genetic | 15 | 1.0 |
Adolescent | 15 | 0.0 |
Adult | 23 | 0.0 |
Bone Marrow/pathology | 2 | 0.0 |
Chromosomes, Human, Pair 12/*genetics | 17 | 14.0 |
DNA Primers/chemistry | 4 | 0.0 |
Gene Amplification | 2 | 0.0 |
Gene Deletion | 9 | 0.0 |
Immunophenotyping | 3 | 0.0 |
Karyotyping | 20 | 1.0 |
Leukemia, Lymphocytic, Acute/*genetics | 10 | 11.0 |
Middle Aged | 24 | 0.0 |
Oncogene Proteins, Fusion/*genetics/metabolism | 3 | 13.0 |
*Chromosome Deletion | 4 | 0.0 |
Chromosome Mapping | 15 | 0.0 |
DNA-Binding Proteins/*genetics | 51 | 2.0 |
Genetic Markers | 4 | 0.0 |
Leukemia, Prolymphocytic/*genetics | 2 | 14.0 |
Leukemia, T-Cell/*genetics | 2 | 8.0 |
Microsatellite Repeats | 4 | 0.0 |
Phosphoproteins/genetics | 2 | 1.0 |
Repressor Proteins/*genetics | 14 | 5.0 |
Transcription, Genetic | 7 | 0.0 |
Amino Acid Sequence | 18 | 0.0 |
Base Sequence | 24 | 0.0 |
CpG Islands | 2 | 0.0 |
DNA, Complementary | 3 | 0.0 |
DNA-Binding Proteins/genetics | 4 | 0.0 |
Molecular Sequence Data | 28 | 0.0 |
Repressor Proteins/genetics | 2 | 1.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Analysis, DNA | 8 | 0.0 |
3T3 Cells | 5 | 0.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
Chromosome Breakage/*genetics | 4 | 7.0 |
Leukemia, Myeloid/etiology/*genetics | 2 | 18.0 |
Transfection | 7 | 0.0 |
Child | 25 | 0.0 |
Child, Preschool | 25 | 0.0 |
Chromosomes, Human, Pair 21 | 5 | 4.0 |
Flow Cytometry | 2 | 0.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
Leukemia, Myeloid, Chronic/*genetics | 3 | 4.0 |
*Proto-Oncogenes | 5 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Chromosome Banding | 5 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Infant | 19 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Survival Analysis | 2 | 0.0 |
*Gene Rearrangement | 5 | 2.0 |
Trisomy | 3 | 2.0 |
Chimeric Proteins/*genetics | 2 | 11.0 |
*Chromosomes, Human, Pair 4 | 2 | 0.0 |
*Protein-Tyrosine Kinase | 3 | 0.0 |
*Translocation, Genetic | 28 | 3.0 |
*Chromosome Aberrations | 7 | 1.0 |
Chromosomes/ultrastructure | 2 | 6.0 |
Leukemia, Myelocytic, Acute/*genetics | 3 | 2.0 |
Models, Genetic | 3 | 0.0 |
In Situ Hybridization, Fluorescence/*methods | 3 | 3.0 |
Leukemia, Lymphocytic, Acute, L1/*genetics | 5 | 12.0 |
Acute Disease | 8 | 0.0 |
Chromosomes, Human, Pair 7/*genetics | 3 | 2.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
Infant, Newborn | 6 | 0.0 |
Oncogene Proteins, Fusion/genetics | 4 | 4.0 |
*Repressor Proteins | 44 | 3.0 |
Transcription Factors/*genetics | 40 | 2.0 |
Chromosome Breakage | 2 | 2.0 |
Chromosomes, Human, Pair 12/*genetics/ultrastructure | 5 | 55.0 |
Leukemia, Lymphocytic, Acute/genetics | 3 | 10.0 |
Leukemia, Myeloid/*genetics | 9 | 6.0 |
Sequence Deletion | 4 | 0.0 |
*Cell Cycle Proteins | 6 | 0.0 |
Microtubule-Associated Proteins/*genetics | 4 | 6.0 |
*Tumor Suppressor Proteins | 6 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Bone Marrow Cells/pathology | 3 | 5.0 |
Chromosome Painting | 2 | 4.0 |
Hematologic Neoplasms/*genetics | 6 | 35.0 |
Chromosomes, Human, Pair 15 | 2 | 1.0 |
RNA, Messenger/analysis | 3 | 0.0 |
DNA, Neoplasm/genetics | 5 | 0.0 |
Polymerase Chain Reaction | 7 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
RNA, Neoplasm/analysis | 2 | 0.0 |
Chromosome Deletion | 3 | 0.0 |
Genes, abl/*genetics | 3 | 17.0 |
Translocation, Genetic/genetics | 5 | 5.0 |
Alternative Splicing | 2 | 0.0 |
*Proto-Oncogene Proteins | 8 | 0.0 |
Oncogene Proteins, Fusion/biosynthesis/*genetics | 2 | 13.0 |
Chromosomes, Human, Pair 12/genetics | 4 | 4.0 |
Chromosomes, Human, Pair 15/*genetics | 2 | 2.0 |
Chromosomes, Human, Pair 7/genetics | 2 | 2.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
COS Cells | 3 | 0.0 |
Cell Line | 4 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Chromosome Breakage/genetics | 2 | 3.0 |
Leukemia/*genetics | 9 | 7.0 |
Nuclear Proteins/genetics | 6 | 2.0 |
Clone Cells | 2 | 0.0 |
Blotting, Southern | 10 | 0.0 |
*Chromosomes, Human, Pair 21 | 2 | 1.0 |
Blotting, Northern | 4 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Mice, SCID | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Mutation | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Fatal Outcome | 3 | 0.0 |
Gene Rearrangement/genetics | 2 | 4.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Exons | 5 | 0.0 |
Gene Fusion | 4 | 4.0 |
Gene Library | 3 | 0.0 |
Physical Chromosome Mapping | 2 | 0.0 |
*Oncogene Proteins, Fusion | 3 | 10.0 |
Gene Rearrangement | 6 | 1.0 |
Chromosome Aberrations | 3 | 0.0 |
Introns | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
*Chromosomes, Human, Pair 15 | 2 | 0.0 |
Receptor, trkC | 2 | 6.0 |
Alleles | 4 | 0.0 |
Chromosomes, Artificial, Yeast | 3 | 0.0 |
Disease-Free Survival | 2 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Oncogene Proteins/genetics | 3 | 4.0 |
Chromosome Aberrations/genetics | 4 | 3.0 |
Chromosome Disorders | 4 | 1.0 |
Heterozygote | 3 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
Dimerization | 2 | 0.0 |
NIH 3T3 Cells | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Chromosomes, Human, Pair 9/genetics | 2 | 1.0 |
Leukemia, Myelocytic, Acute/genetics | 2 | 6.0 |
Myelodysplastic Syndromes/genetics | 2 | 8.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
*Gene Deletion | 3 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Protein p16 | 2 | 1.0 |
Myelodysplastic Syndromes/*genetics | 4 | 5.0 |
Binding Sites | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
RNA, Neoplasm/genetics | 3 | 0.0 |
Hela Cells | 3 | 0.0 |
Protein Isoforms | 2 | 0.0 |
Base Sequence/genetics | 2 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
